ALLR — ALLARITY THERAPEUTICS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 20 家机构在其最新 13F 申报中持有 ALLR(ALLARITY THERAPEUTICS INC),合计申报市值 $1.67M,对应 1.30M 股。按股数计算较上季度增持 6.5%(+51.70K 股),申报市值环比上升 26.1%。持仓集中度较高:前五大持有人占申报市值的 70.3%,前十大的集中度为 91.5%。
与上一季度相比,9 家新建仓位、3 家加仓、3 家减仓、3 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
ALLARITY THERAPEUTICS INC(ALLR)的主要机构持有人包括 SABBY MANAGEMENT, LLC、Renaissance Technologies、Vanguard Group,按 13F 申报市值在本页 42 家持有人中排名居前。
ALLR 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 15 | 1.01M | $1.06M | -1.6% |
| Q2 2026 | 20 | 1.30M | $1.67M | +6.5% |
| Q1 2026 | 14 | 950.61K | $1.04M | +3.6% |
| Q4 2025 | 15 | 1.17M | $1.26M | -4.6% |
| Q3 2025 | 11 | 1.03M | $1.63M | +199.4% |
| Q2 2025 | 10 | 195.09K | $197.04K | +161.3% |
| Q1 2025 | 9 | 92.36K | $86.53K | +10.6% |
| Q4 2024 | 6 | 104.49K | $122.25K | +25.3% |
表内 8 个季度中,机构持股合计增加 868%(Q4 2024 → Q3 2026);单季变动最大的是 Q3 2025(+199.4%)。
前 25 大机构持仓人(Q3 2026) — 15 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 304.80K | $320.04K | 0.00% | 减持 | |
| 171.79K | $180.38K | 0.00% | 持有 | |
| 155.29K | $163.05K | 0.00% | 持有 | |
| 154.80K | $162.54K | 0.00% | 增持 | |
| 74.91K | $78.66K | 0.00% | 持有 | |
| 51.63K | $54.21K | 0.00% | 新进 | |
| 33.08K | $34.00K | 0.00% | 减持 | |
| 24.62K | $25.85K | 0.00% | 减持 | |
| 17.39K | $18.79K | 0.00% | 新进 | |
| 17.62K | $18.50K | 0.00% | 新进 | |
| 5.00K | $5.25K | 0.00% | 新进 | |
| 23 | $24 | 0.00% | 增持 | |
| 3 | $3 | 0.00% | 新进 | |
| 1 | $1 | 0.00% | 持有 | |
| 1 | $1 | 0.00% | 持有 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 20 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 331.51K | $427.65K | 0.00% | 增持 | |
| 171.79K | $221.62K | 0.00% | 持有 | |
| 154.87K | $199.78K | 0.00% | 新进 | |
| 154.87K | $199.78K | 0.00% | 减持 | |
| 98.98K | $127.68K | 0.01% | 新进 | |
| 91.75K | $118.36K | 0.00% | 新进 | |
| 74.91K | $96.64K | 0.00% | 持有 | |
| 36.53K | $47.13K | 0.00% | 减持 | |
| 37.00K | $47.00K | 0.00% | 新进 | |
| 36.02K | $46.47K | 0.00% | 新进 | |
| 27.49K | $35.47K | 0.00% | 持有 | |
| 26.59K | $34.30K | 0.00% | 增持 | |
| 20.88K | $26.94K | 0.00% | 减持 | |
| 17.22K | $22.21K | 0.00% | 新进 | |
| 15.32K | $20.00K | 0.00% | 新进 | |
| 2.65K | $3.42K | 0.00% | 新进 | |
| 22 | $28 | 0.00% | 增持 | |
| 13 | $17 | 0.00% | 新进 | |
| 1 | $1 | 0.00% | 持有 | |
| 1 | $1 | 0.00% | 持有 |
Q1 2026 — 14 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 228.08K | $248.61K | 0.00% | 减持 | |
| 190.39K | $207.53K | 0.00% | 增持 | |
| 171.79K | $187.26K | 0.00% | 新进 | |
| 137.60K | $149.98K | 0.00% | 持有 | |
| 74.91K | $81.66K | 0.00% | 新进 | |
| 48.10K | $52.43K | 0.00% | 增持 | |
| 28.97K | $31.57K | 0.00% | 减持 | |
| 27.49K | $29.97K | 0.00% | 持有 | |
| 23.16K | $25.24K | 0.00% | 减持 | |
| 12.33K | $13.44K | 0.00% | 减持 | |
| 7.77K | $8.46K | 0.00% | 新进 | |
| 1 | $1 | 0.00% | 新进 | |
| 1 | $1 | 0.00% | 持有 | |
| 1 | $1 | 0.00% | 新进 |
Q4 2025 — 15 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 247.61K | $267.42K | 0.00% | 增持 | |
| 246.71K | $266.44K | 0.00% | 持有 | |
| 156.64K | $169.17K | 0.00% | 增持 | |
| 137.60K | $148.61K | 0.00% | 持有 | |
| 100.00K | $108.00K | 0.00% | 新进 | |
| 84.59K | $91.36K | 0.00% | 减持 | |
| 55.54K | $59.98K | 0.00% | 减持 | |
| 33.64K | $36.34K | 0.00% | 新进 | |
| 28.94K | $31.26K | 0.00% | 减持 | |
| 27.49K | $29.69K | 0.00% | 增持 | |
| 26.52K | $28.64K | 0.00% | 新进 | |
| 13.59K | $14.68K | 0.00% | 新进 | |
| 10.35K | $11.00K | 0.00% | 新进 | |
| 140 | $151 | 0.00% | 增持 | |
| 1 | $1 | 0.00% | 持有 |
Q3 2025 — 11 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 278.95K | $440.74K | 0.00% | 新进 | |
| 246.71K | $389.80K | 0.00% | 新进 | |
| 151.93K | $240.04K | 0.00% | 增持 | |
| 137.60K | $217.41K | 0.00% | 新进 | |
| 94.14K | $148.74K | 0.00% | 新进 | |
| 66.19K | $104.57K | 0.00% | 新进 | |
| 43.63K | $68.93K | 0.00% | 新进 | |
| 13.91K | $21.98K | 0.00% | 新进 | |
| 134 | $212 | 0.00% | 减持 | |
| 7 | $10 | 0.00% | 持有 | |
| 1 | $2 | 0.00% | 持有 |
Q2 2025 — 10 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 50.95K | $51.46K | 0.00% | 新进 | |
| 50.65K | $51.16K | 0.00% | 增持 | |
| 47.98K | $48.46K | 0.00% | 增持 | |
| 26.36K | $26.63K | 0.00% | 新进 | |
| 14.45K | $14.60K | 0.00% | 新进 | |
| 3.07K | $3.10K | 0.00% | 减持 | |
| 1.47K | $1.49K | 0.00% | 新进 | |
| 138 | $139 | 0.00% | 增持 | |
| 7 | $7 | 0.00% | 持有 | |
| 1 | $1 | 0.00% | 持有 |
新建仓(Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 154.87K 股 · $199.78K
- Militia Capital Management LLC 98.98K 股 · $127.68K
- Citadel Advisors 91.75K 股 · $118.36K
- HRT FINANCIAL LP 37.00K 股 · $47.00K
- JANE STREET GROUP, LLC 36.02K 股 · $46.47K
- SUSQUEHANNA INTERNATIONAL GROUP, LLP 17.22K 股 · $22.21K
- Virtu Financial LLC 15.32K 股 · $20.00K
- Tower Research Capital LLC (TRC) 2.65K 股 · $3.42K
- Fidelity Management & Research (FMR) 13 股 · $17
完全清仓(较上季)
- STATE STREET CORP 卖出 137.60K 股 · $149.98K
- TWO SIGMA SECURITIES, LLC 卖出 12.33K 股 · $13.44K
- Citigroup Inc 卖出 7.77K 股 · $8.46K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies | 304.80K | 331.51K | 228.08K | 247.61K | 66.19K | — | — | — | — | — | — | — | — | — | — | 38.79K | 25.29K | 86.36K | 114.23K | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 171.79K | 171.79K | 171.79K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 155.29K | 154.87K | 190.39K | 156.64K | 151.93K | 50.65K | 33.92K | — | — | 102.33K | — | — | — | — | — | 29.43K | 29.43K | 29.43K | 12.31K | — |
| STATE STREET CORP | 154.80K | — | 137.60K | 137.60K | 137.60K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 74.91K | 74.91K | 74.91K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Focus Partners Wealth | 51.63K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HRT FINANCIAL LP | 33.08K | 37.00K | — | 10.35K | — | — | — | — | — | 34.69K | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 24.62K | 26.59K | 23.16K | 26.52K | — | 47.98K | 300 | — | 18.45K | 41.21K | 33.03K | — | — | 3.62K | 1 | 39 | 13.95K | 2.04K | 4.48K | 109 |
| StoneX Group Inc. | 17.39K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Citigroup Inc | 17.62K | — | 7.77K | — | — | 1.47K | — | 12.29K | — | — | — | — | — | — | — | — | — | 32.56K | 10.08K | — |
| Morgan Stanley | 5.00K | — | — | — | — | — | 23.31K | — | — | — | 7 | — | — | — | 4 | 28.71K | 151 | 148 | 31.91K | — |
| Caitong International Asset Management Co., Ltd | 23 | 22 | 1 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BARCLAYS PLC | 3 | — | — | — | — | — | 10.08K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| DANSKE BANK A/S | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 | — | — | — | — | — | — | — | — | — | — | — |
| JONES FINANCIAL COMPANIES LLLP | 1 | 1 | 1 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SABBY MANAGEMENT, LLC | — | — | — | — | — | — | — | — | — | — | — | — | 359.40K | — | — | — | — | — | — | — |
| Private Advisor Group, LLC | — | — | — | 55.54K | 278.95K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Vanguard Group | — | — | — | 246.71K | 246.71K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| GEODE CAPITAL MANAGEMENT, LLC | — | 154.87K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ARMISTICE CAPITAL, LLC | — | — | — | — | — | — | — | — | — | — | — | — | 261.00K | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold ALLR?
As of 2026-Q2, 20 institutional funds reported holding ALLR (ALLARITY THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $1.67M.
How many shares of ALLR do institutions own?
13F filers reported 1.30M shares of ALLR, worth $1.67M in aggregate at the end of 2026-Q2.
Is institutional ownership of ALLR rising or falling?
Share counts moved +6.5% versus the prior quarter — accumulation.
Who are the top institutional holders of ALLR?
The largest 13F holders are SABBY MANAGEMENT, LLC, Renaissance Technologies, Vanguard Group, GEODE CAPITAL MANAGEMENT, LLC, ARMISTICE CAPITAL, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of ALLARITY THERAPEUTICS INC?
The major shareholders of ALLARITY THERAPEUTICS INC (ALLR) by reported 13F value are SABBY MANAGEMENT, LLC, Renaissance Technologies, Vanguard Group, GEODE CAPITAL MANAGEMENT, LLC, ARMISTICE CAPITAL, LLC, among 42 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.